Cargando…
Rapid Point-of-Care Genotyping to Avoid Aminoglycoside-Induced Ototoxicity in Neonatal Intensive Care
IMPORTANCE: Aminoglycosides are commonly prescribed antibiotics used for the treatment of neonatal sepsis. The MT-RNR1 m.1555A>G variant predisposes to profound aminoglycoside-induced ototoxicity (AIO). Current genotyping approaches take several days, which is unfeasible in acute settings. OBJECT...
Autores principales: | McDermott, John H., Mahaveer, Ajit, James, Rachel A., Booth, Nicola, Turner, Mark, Harvey, Karen E., Miele, Gino, Beaman, Glenda M., Stoddard, Duncan C., Tricker, Karen, Corry, Rachel J., Garlick, Julia, Ainsworth, Shaun, Beevers, Thomas, Bruce, Iain A., Body, Richard, Ulph, Fiona, MacLeod, Rhona, Roberts, Peter L., Wilson, Paul M., Newman, William G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938898/ https://www.ncbi.nlm.nih.gov/pubmed/35311942 http://dx.doi.org/10.1001/jamapediatrics.2022.0187 |
Ejemplares similares
-
Pharmacogenetics to Avoid Loss of Hearing (PALOH) trial: a protocol for a prospective observational implementation trial
por: McDermott, John Henry, et al.
Publicado: (2021) -
Ototoxicity of Non-aminoglycoside Antibiotics
por: Rybak, Leonard P., et al.
Publicado: (2021) -
Diagnosing and Preventing Hearing Loss in the Genomic
Age
por: McDermott, John H., et al.
Publicado: (2019) -
Mechanism and Prevention of Ototoxicity Induced by Aminoglycosides
por: Fu, Xiaolong, et al.
Publicado: (2021) -
Mechanisms of Aminoglycoside- and Cisplatin-Induced Ototoxicity
por: Steyger, Peter S.
Publicado: (2021)